Federal Grants for Health



Department of Health and Human Services
 $62,853,680,968 Department of Transportation
 $56,443,571,981 Environmental Protection Agency
 $35,751,587,496 Department of Energy
 $24,661,368,000 National Aeronautics and Space Administration
 $14,032,768,821 Department of Homeland Security
 $13,986,266,741 Department of Labor
 $10,348,285,755 Department of Defense
 $10,111,366,675 Department of the Interior
 $9,806,569,960 Department of Agriculture
 $8,296,397,040 Agency for International Development
 $7,754,781,106 Department of Commerce
 $6,871,103,950 Department of Housing and Urban Development
 $6,642,477,476 Department of State
 $6,042,701,916 Department of Justice
 $5,571,395,802 Department of Education
 $2,642,831,221 Department of the Treasury
 $1,019,380,000 Other Agencies
 $724,036,487


Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)

National Institutes of Health
The purpose of this proposed Notice of Funding Announcement (NOFO) is to support development of biomarkers or clinical outcomes derived from digital health technology (DHT) for use in clinical trials...more
Posted On - 2024-11-13


NIMHD Minority Health and Health Disparities Research Training (MHRT) Program (T37 Clinical Trial Not Allowed)

National Institutes of Health
The purpose of this Notice of Funding Opportunity (NOFO) is to support research training activities in minority health and health disparities research for individuals from diverse backgrounds,...more
Posted On - 2024-11-13


Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)

National Institutes of Health
The purpose of this PAR is to support policy research projects that examine new or adapted policies pertaining to tobacco, alcohol, and/or cannabis in the U.S., with a particular focus on how the...more
Posted On - 2024-11-13




Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)

National Institutes of Health
The purpose of this PAR is to support policy research projects that examine new or adapted policies pertaining to tobacco, alcohol, and/or cannabis in the U.S., with a particular focus on how the...more
Posted On - 2024-11-13


Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (R21 - Clinical Trial Not Allowed)

National Institutes of Health
The purpose of this initiative are to accelerate research leading to improved understanding and treatments for Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy...more
Posted On - 2024-11-13


Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)

National Institutes of Health
Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) intends to support the rigorous assessment of barriers to quality cancer treatment and follow-up care for sexual...more
Posted On - 2024-11-12


Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)

National Institutes of Health
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to utilize bacteria, archaebacteria, bacteriophages, or other...more
Posted On - 2024-11-12




Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional)

National Institutes of Health
This Notice of Funding Opportunity (NOFO) invites implementation research applications to develop, optimize, and test innovative theory-based strategies to integrate mental health care into health...more
Posted On - 2024-11-12


Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

National Institutes of Health
This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying...more
Posted On - 2024-11-12




In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.






More Federal Domestic Assistance Programs


Education, Training, and Enhanced Services to End Violence Against and Abuse of Women with Disabilit | Health Information Technology Regional Extension Centers Program | Program of Protection and Advocacy of Individual Rights | Agriscience Awards | Autism and Other Developmental Disabilities, Surveillance, Research, and Prevention |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2025 Copyright Michael Saunders